Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The International Journal of Biological Markers|February 26, 2024
Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerationsElia Cappelletto, Laura Tiozzo Fasiolo, Valentina Salizzato, et al.
Cancers|April 16, 2020
TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma PatientsPaola Del Bianco, Camilla Stagni, Silvia Giunco, et al.
International Journal of Oncology|October 9, 2013
Preoperative treatment of locally advanced esophageal carcinoma (Review)Michele Orditura, Gennaro Galizia, Alessio Fabozzi, et al.
World Journal of Gastroenterology|March 4, 2014
Treatment of gastric cancerMichele Orditura, Gennaro Galizia, Vincenzo Sforza, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 5, 2021
The immune cell landscape of metastatic uveal melanoma correlates with overall survivalAnna Tosi, Rocco Cappellesso, Angelo Paolo Dei Tos, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|October 4, 2016
Applicability of the Proposed Japanese Model for the Classification of Gastric Cancer Location: The "PROTRADIST" Retrospective StudyLuigi Marano, Marianna Petrillo, Modestino Pezzella, et al.
Cancers|September 26, 2018
Prognostic Factors in Merkel Cell Carcinoma: A Retrospective Single-Center Study in 90 PatientsMarco Rastrelli, Beatrice Ferrazzi, Francesco Cavallin, et al.
Biology|November 27, 2024
Polygenic Risk Score Improves Melanoma Risk Assessment in a Patient Cohort from the Veneto Region of ItalyStefania Pellegrini, Thomas P Potjer, Paola Del Bianco, et al.
BMC Cancer|September 4, 2016
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practiceFerdinando De Vita, Jole Ventriglia, Antonio Febbraro, et al.
Molecular Cancer Therapeutics|April 8, 2018
<i>BRAF</i> Gene Copy Number and Mutant Allele Frequency Correlate with Time to Progression in Metastatic Melanoma Patients Treated with MAPK InhibitorsCamilla Stagni, Carolina Zamuner, Lisa Elefanti, et al.
Pageof 4